Compare RNW & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNW | PBH |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 2021 | 2004 |
| Metric | RNW | PBH |
|---|---|---|
| Price | $6.96 | $48.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $7.78 | ★ $66.20 |
| AVG Volume (30 Days) | ★ 1.5M | 564.9K |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $18.42 | $17.88 |
| Revenue Next Year | $18.46 | $6.80 |
| P/E Ratio | ★ $14.63 | $42.11 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $4.39 | $41.77 |
| 52 Week High | $7.69 | $71.07 |
| Indicator | RNW | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 66.73 | 53.18 |
| Support Level | $6.83 | $47.23 |
| Resistance Level | N/A | $50.26 |
| Average True Range (ATR) | 0.03 | 1.92 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 88.89 | 56.41 |
ReNew Energy Global PLC is a developer and operator of clean energy projects. Additionally, it provides clean energy solutions and value-added energy offerings through digitalization, storage, and carbon market services that are increasingly integral to addressing climate change. The company has two reportable segments: Generation and sale of renewable power and Manufacturing of power equipment. The majority of its revenue is generated from the Generation and sale of renewable power segment, which reflects the revenue earned from its utility-scale wind energy projects, solar energy projects, and hydro energy projects. The Manufacturing of power equipment segment relates to the manufacturing of solar panels and modules. Geographically, all of its material revenues are generated from India.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.